The team is optimizing the cancer genome analysis system to integrate it into CRC diagnosis and tailor treatments based on genetic mutations.

Researchers used mutational analysis to identify gene mutations that may drive carcinogenesis in colorectal tumors with high ...

Favorable initial results from a phase 1/2 trial of solnerstotug in PD-L1–resistant tumors showed a 14% response rate and 62% disease control rate. Researchers have found childhood cancer survivors ...

Colorectal cancer (CRC), a type of cancer that affects the large intestine and rectum, is one of the leading causes of cancer-related deaths ...

Colorectal cancer (CRC), a type of cancer that affects ... normal epithelial cells transition to adenoma (non-cancerous tumor) and then to carcinoma (cancerous tumor) as they sequentially acquire ...

Investigators assessed whether a reported survival disadvantage in men with secondary rectal cancer following prostate cancer radiation therapy vs primary rectal cancer is due to patient ...

Colorectal cancer (CRC), a type of cancer that affects ... normal epithelial cells transition to adenoma (non-cancerous tumor) and then to carcinoma (cancerous tumor) as they sequentially acquire ...

A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" ...

KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic ...